Follow on Google News News By Tag * Pcr * Hot Start * Cleanamp * Dntp * Trilink * Biofortuna * Diagnostic * Pcr Kit * Transplantation * Sequence-specific Primer * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | TriLink BioTechnologies, Inc. Announces License Agreement with Biofortuna Ltd.TriLink BioTechnologies, Inc. (TriLink) announced that it has signed a licensing agreement with Biofortuna Ltd. (Biofortuna) for use of CleanAmp™ dNTPs in Biofortuna’s freeze dried in vitro diagnostic PCR kits.
By: TriLink BioTechnologies CleanAmp™ dNTPs gave Biofortuna a viable alternative to the more commonly-used approaches to Hot Start PCR. Biofortuna was able to improve the specificity of their genotyping assays by replacement of the standard dNTPs with CleanAmp™ dNTPs. “Combining CleanAmp™ dNTPs with our novel lyophilisation methods creates the ultimate in high quality easy-to-use PCR assays. All Biofortuna freeze-dried kits are self-contained, including polymerase: to perform the test, all the customer has to do is add DNA to the assay and then PCR. Inclusion of CleanAmp™ dNTPs allows us to create accurate, reproducible and simple diagnostic kits, that greatly improve the quality of clinical testing and patient care,” said Biofortuna CEO, Dr. Mike Bunce. “CleanAmp™ “CleanAmp™ “The ability to provide emerging companies with a cost-effective, easy-to-commercialize solution for high stringency PCR kits was the main driving force behind the development of our CleanAmp™ Products. We are excited to see our collaboration with the innovative people at Biofortuna come to fruition,” said TriLink CEO, Dr. Richard Hogrefe. About TriLink TriLink BioTechnologies, Inc. manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the diagnostic and OEM markets. In addition, custom chemistry, contract research services and ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 80 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email info@trilinkbiotech.com, or visit our web site at www.trilinkbiotech.com. For more information contact: TriLink BioTechnologies, Inc. Shawna Leaver 858-546-0004 / 800-863-6801 sleaver@trilinkbiotech.com About Biofortuna Biofortuna is an award-winning molecular diagnostics company providing easy-to-use, high quality HLA molecular diagnostics. Biofortuna have created the world’s first freeze dried PCR reactions. Users simply add DNA to pre-dispensed, freeze dried PCR reactions allowing for the ultimate in user convenience. Biofortuna’s diagnostic kits are simple, quick and consistent, providing accurate, high quality results. The kits superior stability allows storage and transportation at ambient temperature eliminating the requirement for fridges, freezers and thermally controlled shipping. With their patented freeze dried technology, expertise in HLA, and a passion for quality, Biofortuna’s diagnostic kits offer significant advantages over its competitors. For more information about the company and products please contact: Harry Singh Commercial Director Biofortuna Ltd harry.singh@ www.biofortuna.com Tel: +44 (0) 151 334 0182 # # # TriLink BioTechnologies manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products. In addition, custom chemistry, contract research services and ISO/QSR compliant cGMP production facilities are offered. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|